Skip to main content
Year archive

ERYTECH Pharma S.A. — 2022 filings

All 57 regulatory filings released by ERYTECH Pharma S.A. (ERYP) in 2022, sourced directly from the official regulator.

57 Filings
2022 Period
2022 filings (57)
Filing Released Lang
Franchissement de seuil
Major Shareholding Notification
2022-12-14 French
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 novembre 2022
Declaration of Voting Results & Voting Rights Announcements
2022-12-06 French
Monthly information related to total number of voting rights and shares composing the share capital _October 30, 2022
Declaration of Voting Results & Voting Rights Announcements
2022-12-06 English
Franchissement de seuil
Major Shareholding Notification
2022-11-23 French
ERYTECH fait le point sur ses activités et publie ses résultats du troisième trimestre 2022
Earnings Release 9M 2022
2022-11-21 French
ERYTECH Provides Business and Financial Update for the Third Quarter of 2022
Earnings Release 9M 2022
2022-11-21 English
ERYTECH reçoit une notification du Nasdaq
Regulatory Filings
2022-10-13 French
ERYTECH Announces Receipt of Nasdaq Notice
Delisting Announcement
2022-10-13 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2022
Share Issue/Capital Change
2022-10-04 French
Monthly information related to total number of voting rights and shares composing the share capital _September 30, 2022
Share Issue/Capital Change
2022-10-04 English
ERYTECH PHARMA - RAPPORT FINANCIER SEMESTRIEL AU 30 JUIN 2022
Interim / Quarterly Report H1 2022
2022-09-12 French
ERYTECH Provides Business and Financial Update for the First Half of 2022
Interim / Quarterly Report H2 2022
2022-09-12 English
ERYTECH fait le point sur ses activités et publie ses résultats semestriels 2022
Interim / Quarterly Report H1 2022
2022-09-12 French
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2022
Share Issue/Capital Change
2022-09-06 French
Monthly information related to total number of voting rights and shares composing the share capital _August 31, 2022
Regulatory Filings
2022-09-06 English
ERYTECH Provides Regulatory Update
Regulatory Filings
2022-08-24 English
ERYTECH fait le point sur son activité réglementaire
Legal Proceedings Report
2022-08-24 French
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 juin 2022
Declaration of Voting Results & Voting Rights Announcements
2022-07-07 French
Monthly information related to total number of voting rights and shares composing the share capital _June 30, 2022.
Declaration of Voting Results & Voting Rights Announcements
2022-07-07 English
Compte Rendu – Assemblée Générale Mixte d’ERYTECH du 24 Juin 2022
AGM Information
2022-06-24 French
Report – ERYTECH’s Combined Shareholders’ Meeting On June 24, 2022
AGM Information
2022-06-24 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 mai 2022
Declaration of Voting Results & Voting Rights Announcements
2022-06-03 French
Monthly information related to total number of voting rights and shares composing the share capital _May 31, 2022.
Declaration of Voting Results & Voting Rights Announcements
2022-06-03 English
ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 24, 2022
AGM Information
2022-05-24 English
ERYTECH annonce les modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 24 juin 2022
AGM Information
2022-05-24 French
ERYTECH tiendra une présentation à la conférence H.C. Wainwright Global Investment
Regulatory Filings
2022-05-17 French
ERYTECH to Present at the H.C. Wainwright Global Investment Conference
Regulatory Filings
2022-05-17 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2022
Share Issue/Capital Change
2022-05-13 French
Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2022
Regulatory Filings
2022-05-13 English
ERYTECH fait le point sur ses activités et publie ses résultats financiers du premier trimestre 2022
Interim / Quarterly Report Q1 2022
2022-05-12 French
ERYTECH Provides Business and Financial Update for the First Quarter of 2022
Interim / Quarterly Report Q1 2022
2022-05-12 English
ERYTECH annonce le dépôt de son Document d’Enregistrement Universel 2021 et de son Form 20-F 2021, ainsi que son calendrier financier 2022
Report Publication Announcement
2022-04-28 French
ERYTECH Announces Filing of 2021 Universal Registration Document and 2021 Annual Report on Form 20-F, as well as its 2022 financial calendar
Report Publication Announcement
2022-04-28 English
Document d'Enregistrement Universel 2021
Annual Report (ESEF) FY 2021
2022-04-27 French
Franchissement de seuils
Major Shareholding Notification
2022-04-14 French
ERYTECH annonce la publication des résultats positifs de l’essai de phase 2 évaluant eryaspase dans la LAL hypersensible au British Journal of Haematology
Earnings Release FY 2022
2022-04-06 French
ERYTECH Announces Publication of Positive Results from Eryaspase Phase 2 Trial in Hypersensitive ALL in the British Journal of Haematology
Regulatory Filings
2022-04-06 English
Monthly information related to total number of voting rights and shares composing the share capital – March 31, 2022
Declaration of Voting Results & Voting Rights Announcements
2022-04-06 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 mars 2022
Declaration of Voting Results & Voting Rights Announcements
2022-04-06 French
ERYTECH to Present Novel Vesiculation Approach at the 24th Meeting of the European Red Cell Society
Regulatory Filings
2022-04-04 English
ERYTECH présentera une nouvelle approche de vésiculation au 24ème congrès de la Société Européenne des Globules Rouges (ERCS)
Regulatory Filings
2022-04-04 French
ERYTECH annonce sa participation à des conférences investisseurs en avril
Report Publication Announcement
2022-03-28 French
ERYTECH to Participate in the Upcoming April Investor Conferences
Investor Presentation
2022-03-28 English
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2021
Earnings Release Q4 2021
2022-03-11 English
ERYTECH fait le point sur ses activités et publie sa position de trésorerie pour l’exercice 2021
Management Reports
2022-03-11 French
Monthly information related to total number of voting rights and shares composing the share capital – February 28, 2022
Share Issue/Capital Change
2022-03-04 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 28 février 2022
Share Issue/Capital Change
2022-03-04 French
ERYTECH élargit son portefeuille de brevets dans le traitement de maladies métaboliques rares
Regulatory Filings
2022-02-08 French
ERYTECH Expands Patent Portfolio for the Treatment of Rare Metabolic Diseases
Regulatory Filings
2022-02-08 English
Monthly information related to total number of voting rights and shares composing the share capital – January 31, 2022
Declaration of Voting Results & Voting Rights Announcements
2022-02-08 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2022
Share Issue/Capital Change
2022-02-08 French
ERYTECH annonce la présentation des résultats de deux études cliniques évaluant eryaspase dans le traitement du cancer du pancréas lors du symposium ASCO-GI
Regulatory Filings
2022-01-24 French
ERYTECH Announces Presentation of Results of Two Clinical Trials of Eryaspase in Pancreatic Cancer at ASCO GI
Earnings Release FY 2021
2022-01-24 English
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 décembre 2021
Declaration of Voting Results & Voting Rights Announcements
2022-01-10 French
Monthly information related to total number of voting rights and shares composing the share capital – December 31, 2021
Declaration of Voting Results & Voting Rights Announcements
2022-01-10 English
ERYTECH annonce sa participation en janvier à des conférences investisseurs virtuelles
Report Publication Announcement
2022-01-03 French
ERYTECH to Participate in the Upcoming January Virtual Investor Conferences
Regulatory Filings
2022-01-03 English